Trademark Filing

Genexine, Inc.

Application Filed: 2023-12-22
Trademark Application Details
Trademark Logo
630
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Serial Number79391354
Mark Drawing Code0000:

Timeline

2023-12-22Application Filed
2024-03-14Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM)
2024-03-14Status: Live/Pending
2024-03-14Transaction Date

Trademark Applicants & Owners

Owner: Genexine, Inc.
Entity StatementCORPORATION
Address(Magokdong, Bio Innovation Park) 172, Magokjungang-ro, Gangseo-gu Seoul 07789 KR
Legal Entity TypeCorporation

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

?




Good, Services, and Codes

International Codes:5
U.S. Codes:052,051,005,018,006,044,046
Type CodeType
GS0051Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment; biological preparations for medical purposes; cardiovascular agents for medical purposes; drugs for medical purposes; synthetic peptides for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; anemia treatment medicines that stimulate red blood cell production; medicines to stimulate red blood cell production; medicines for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes; synthetic peptides for pharmaceutical and anemia treatment purposes; synthetic peptides for pharmaceutical and kidney disease treatment purposes.

Trademark Filing History

DescriptionDateEvent Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB2024-03-141 REPR M:
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2024-03-222 NWOS I:Incoming Correspondence
APPLICATION FILING RECEIPT MAILED2024-04-243 MAFR O:Outgoing Correspondence
ASSIGNED TO EXAMINER2024-07-234 DOCK D:Assigned to Examiner
NON-FINAL ACTION WRITTEN2024-07-235 CNRT R:Renewal
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW2024-07-246 RFCR E:E-Mail
REFUSAL PROCESSED BY MPU2024-08-087 RFRR P:
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB2024-08-088 RFCS P:

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed